Actively Recruiting
Wise Practice of Chinese Hemodialysis (WISHES)
Led by Sun Yat-sen University · Updated on 2020-10-22
30000
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are enrolling patients with end stage renal disease (ESRD) who are receiving hemodialysis (HD) treatment to create a comprehensive HD database in China. This observational study aims to collect and compare patient survival, technical survival, access patency rates, quality of life, and residual kidney function among HD patients. The study is led by Sun Yat-sen University and includes patients treated at multiple hospitals. Participants have their demographic details, clinical characteristics, complications, medications, and quality of life measured at the start and then every 3 months during follow-up visits. Information recorded includes blood pressure, causes of ESRD, lab tests, and treatment outcomes such as mortality, kidney transplantation, access failure, hospitalizations, and transfer to other dialysis methods. During the study, patients are regularly assessed every three months with updates entered into the registration system. Researchers use this data to evaluate key outcomes like patient survival over 10 years, quality of life using the SF36 scale, and access patency rates. This ongoing follow-up helps provide detailed insights into the experiences and health of HD patients over time.
CONDITIONS
Brief Title
Wise Practice of Chinese Hemodialysis (WISHES)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- End stage renal disease patients receiving hemodialysis treatment
You will not qualify if you...
- No exclusion criteria specified
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants receiving routine hemodialysis treatment are observed. Demographic and clinical characteristics, complications, drug information, and outcomes such as mortality and hospitalization are collected.
Visits every 3 months
Trial Site Locations
Total: 1 location
1
The 1st Affiliated Hospital, Sun Yet-sen University
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
X
Xueqing Yu, M.D. & Ph.D.
X
Xunhua Zheng, M.D. & Ph.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here